Chapter

The Development of Munich and Cambridge Therapeutic Biotech Firms: A Case Study of Institutional Adaptation

Simcha Jong

in Innovation in Local Economies

Published in print April 2009 | ISBN: 9780199551170
Published online May 2009 | e-ISBN: 9780191720802 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780199551170.003.0006
The Development of Munich and Cambridge Therapeutic Biotech Firms: A Case Study of Institutional Adaptation

Show Summary Details

Preview

In order to understand better the development of the therapeutic biotech firms in the Munich region, Germany's largest and most successful biotech cluster, this chapter contrasts the development of Munich firms with that in the Cambridge region in the UK. The chapter proceeds as follows. First, it discusses how the comparative case study will increase the understanding of the mechanisms through which entrepreneurs in a new industry are able to overcome pre-existing institutional barriers to their firms' development. Second, it outlines the main organizational challenges with which biotech entrepreneurs in Cambridge and Munich have been confronted in building up a biotech firm. Third, it analyzes how Munich's and Cambridge's therapeutic biotech firms have relied on their institutional environments differently to develop their firms' capabilities to deal with these organizational challenges. Fourth, it discusses how the different institutional paths which Cambridge's and Munich's biotech entrepreneurs have followed to deal with key organizational challenges have affected the development of these firms. Finally, the main findings are summarized and some implications of this study for broader debates in the comparative institutional literature are suggested.

Keywords: biotechnology; Munich; Cambridge; inter-company relations; entrepreneurs; institutional environments

Chapter.  7432 words.  Illustrated.

Subjects: Political Economy

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.